16 results on '"Pedrol, Enric"'
Search Results
2. Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZIP Study
3. Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients
4. Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leukoencephalopathy: Results of an Observational Multicenter Study
5. Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults
6. Reply to Crane et al., ‘Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir’
7. Effect of Genetic Variants of CCR2 and CCL2 on the Natural History of HIV-1 Infection
8. Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients
9. Absence of CXCR4 C-Terminal Polymorphisms in HIV-1-Infected and Uninfected Spaniards
10. Polymorphism of RANTES Chemokine Gene Promoter Is Not Associated With Long-Term Nonprogressive HIV-1 Infection of More Than 16 Years
11. Spanish HIV-1-Infected Long-Term Nonprogressors of More Than 15 Years Have an Increased Frequency of the CX3CR1 249I Variant Allele
12. Lack of Association of SDF-1 3′A Variant Allele With Long-Term Nonprogressive HIV-1 Infection Is Extended Beyond 16 Years
13. Upregulatory Mechanisms Compensate for Mitochondrial DNA Depletion in Asymptomatic Individuals Receiving Stavudine Plus Didanosine
14. Mitochondrial involvement in antiretroviral therapy-related lipodystrophy
15. Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy
16. Central nervous system toxoplasmosis in AIDS patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.